Evidence for an AFP-mediated induction of tolerogenic DCs came from a tumor model where AFP has been demonstrated to induce tolerogenic DC capable of suppressing tumor-specific CD8+ cytotoxic T lymphocytes within the tumor (114). Here, CD8A is linked to neoplasm.